- Home
- NERV vs EEIQ Comparison
NERV vs EEIQ Comparison
Compare NERV & EEIQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NERV
- EEIQ
- Stock Information
- Founded
- NERV 2007
- EEIQ 2017
- Country
- NERV United States
- EEIQ United States
- Employees
- NERV N/A
- EEIQ 60
- Industry
- NERV Biotechnology: Pharmaceutical Preparations
- EEIQ Other Consumer Services
- Sector
- NERV Health Care
- EEIQ Real Estate
- Exchange
- NERV Nasdaq
- EEIQ Nasdaq
- Market Cap
- NERV 15.5M
- EEIQ 11.3M
- IPO Year
- NERV 2014
- EEIQ 2021
- Fundamental
- Price
- NERV $1.82
- EEIQ $0.85
- Analyst Decision
- NERV Hold
- EEIQ
- Analyst Count
- NERV 1
- EEIQ 0
- Target Price
- NERV $5.00
- EEIQ N/A
- AVG Volume (30 Days)
- NERV 77.1K
- EEIQ 3.2K
- Earning Date
- NERV 03-04-2025
- EEIQ 03-04-2025
- Dividend Yield
- NERV N/A
- EEIQ N/A
- EPS Growth
- NERV N/A
- EEIQ N/A
- EPS
- NERV N/A
- EEIQ N/A
- Revenue
- NERV N/A
- EEIQ $8,153,546.00
- Revenue This Year
- NERV N/A
- EEIQ N/A
- Revenue Next Year
- NERV N/A
- EEIQ N/A
- P/E Ratio
- NERV N/A
- EEIQ N/A
- Revenue Growth
- NERV N/A
- EEIQ 42.73
- 52 Week Low
- NERV $1.77
- EEIQ $0.60
- 52 Week High
- NERV $7.53
- EEIQ $1.44
- Technical
- Relative Strength Index (RSI)
- NERV 34.70
- EEIQ 32.89
- Support Level
- NERV $1.77
- EEIQ $0.87
- Resistance Level
- NERV $2.05
- EEIQ $1.01
- Average True Range (ATR)
- NERV 0.16
- EEIQ 0.05
- MACD
- NERV -0.04
- EEIQ -0.01
- Stochastic Oscillator
- NERV 6.41
- EEIQ 0.00
About NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system diseases. The company's pipeline products include MIN-101, MIN-202, and MIN-301. Targeted disorders include schizophrenia, insomnia, depressive disorder, and Parkinson's disease. Its product portfolio and potential indications include Roluperidone for the treatment of negative symptoms in patients with schizophrenia; Seltorexant, for the treatment of insomnia disorder and depressive disorder; MIN-117 for the treatment of MDD; and MIN-301 for the treatment of Parkinson's disease.
About EEIQ EpicQuest Education Group International Limited
EpicQuest Education Group International Ltd provides comprehensive education solutions for domestic and international students interested in university and college degree programs in the U.S., Canada, and the UK. In addition, the company has a recruiting relationship with the regional campuses of Miami University of Ohio, where it maintains residential facilities, a full-service cafeteria, recreational facilities, shuttle buses, and an office for the regional campuses that provides study abroad and post-study services for its students; these facilities are not owned, maintained, operated or are part of Miami University. Company operated in three primary reportable segments foreign language education (QHI), foreign language education (RIL) and the professional training programs.